Recent studies have been publicly and quietly released within the last few months, and those who have received one, two, or multiple shots of the Covid-19 vaccine should be paying attention.
A 2022 investigated study by the JAMA Network that is now making the rounds revealed that researchers and scientists studied 1,626 cases of myocarditis after receiving a Covid-19 vaccine in a national passive reporting system between December 2020 and August 2021.
The numbers speak for themselves.
Men and women between multiple age groups were observed seven days after receiving a Covid-19 vaccine shot.
Learn the benefits of becoming a Valuetainment Member and subscribe today!
What were the results? The rates of myocarditis cases were highest after the second vaccination dose in adolescent males aged 12- to 24-year-olds.
That means that “Based on passive surveillance reporting in the US, the risk of myocarditis after receiving mRNA-based COVID-19 vaccines was increased across multiple age and sex strata and was highest after the second vaccination dose in adolescent males and young men.”
The results stated that “Between December 14, 2020, and August 31, 2021, 192,405,448 individuals older than 12 years of age received a total of 354, 100, 845 mRNA-based COVID-19 vaccines. VAERS received 1,991 reports of myocarditis (391 of which also included pericarditis) after receipt of at least one dose of mRNA-based COVID-19 vaccine and 684 reports of pericarditis without the presence of myocarditis.”
Further details show:
- Males comprised 82% (1334/1625) of the cases of myocarditis for whom sex was reported.
- The largest proportions of cases of myocarditis were among White persons (non-Hispanic or ethnicity not reported; 69% [914/1330]) and Hispanic persons (of all races; 17% [228/1330]).
- Among persons younger than 30 years of age, there were no confirmed cases of myocarditis in those who died after mRNA-based COVID-19 vaccination without another identifiable cause and there was one probable case of myocarditis but there was insufficient information available for a thorough investigation.
- At the time of data review, there were two reports of death in persons younger than 30 years of age with potential myocarditis that remain under investigation and are not included in the case counts.
The study concluded that the risk of myocarditis after receiving mRNA-based COVID-19 vaccines in the U.S. increased across both sexes and multiple ages — an even higher increase after the second vaccination dose in adolescent males and young men.
The study was released in January 2022 stating that “This risk should be considered in the context of the benefits of COVID-19 vaccination.”
It makes one wonder why these risks, (still labeled as “misinformation” on social media) were kept from the public for so long and are now quietly being released.
Add comment